Maze Therapeutics, Inc. Common Stock MAZE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$122.54M+6.5% | -$131.12M— | —— | —— | —— | ||
| $2.16M-10.0% | $2.4M-7.9% | $2.61M-7.7% | $2.83M-6.8% | $3.03M-8.1% | ||
| $20.28M+23.7% | $16.4M+24.4% | $13.18M+13.0% | $11.66M+10.4% | $10.56M+9.5% | ||
| -$121.54M-8.6% | -$111.94M— | —— | —— | —— | ||
| $588K-25.9% | $794K-41.8% | $1.37M-2.5% | $1.4M+20.0% | $1.17M+1.7% | ||
| -$164.39M+3.8% | -$170.96M-151% | -$68.18M-4,770% | -$1.4M-20.0% | -$1.17M-1.7% | ||
| —— | —— | —— | —— | —— | ||
| $190.32M-30.9% | $275.34M-19.5% | $342.01M+72.5% | $198.25M+0.2% | $197.79M+108% | ||
| -$95.61M-1,164% | -$7.57M-105% | $167.17M— | —— | —— | ||
| -$122.13M-8.3% | -$112.73M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maze Therapeutics, Inc. Common Stock generate?
- Maze Therapeutics, Inc. Common Stock (MAZE) generated -$121.5M in operating cash flow over the trailing twelve months.
- What is Maze Therapeutics, Inc. Common Stock's free cash flow?
- After $588.0K of capital expenditures, Maze Therapeutics, Inc. Common Stock's free cash flow was -$122.1M over the trailing twelve months.
- Where does Maze Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Maze Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
